Companies /Healthcare

APMD

APMD Biotechnology
$27.45
▼ $0.36 (−1.29%) today
Markets closed · 7:07pm ET
Today · % change

Fundamentals

Market Cap
$1.2B
P/E Ratio
11.5
Profit Margin
-26.5%
Revenue (TTM)
$120.2M
EPS (TTM)
$2.41
52-Week Range
$16 – $35
Street Target
$50.33

About APMD

Apnimed, Inc. is a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. The company is headquartered in Cambridge, Massachusetts.

APMD Coverage